0001182489-15-000606.txt : 20150701
0001182489-15-000606.hdr.sgml : 20150701
20150701101745
ACCESSION NUMBER: 0001182489-15-000606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150701
DATE AS OF CHANGE: 20150701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATEL RAJIV A
CENTRAL INDEX KEY: 0001275110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 15963473
MAIL ADDRESS:
STREET 1: C/O FARALLON CAPITAL MANAGEMENT, L.L.C.
STREET 2: ONE MARITIME PLAZA, SUITE 2100
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
4
1
edgar.xml
FORM 4 -
X0306
4
2015-06-30
0
0001618561
Nexvet Biopharma plc
NVET
0001275110
PATEL RAJIV A
C/O FARALLON CAPITAL MANAGEMENT, L.L.C.
ONE MARITIME PLAZA, SUITE 2100
SAN FRANCISCO
CA
94111
1
0
1
1
Member of Group Owning 10%
Ordinary Shares
2015-06-30
4
M
0
1400
0.125
A
2380
D
Ordinary Shares
2499996
I
See Footnotes
Restricted Share Units
2015-06-30
4
M
0
500
0
D
Ordinary Shares
500
5000
D
Restricted Share Units
2015-06-30
4
M
0
900
0
D
Ordinary Shares
900
0
D
Each Restricted Share Unit ("RSU") is convertible into one ordinary share of the Issuer upon vesting, subject to payment by the holder to the Issuer of the nominal value per share ($0.125) within 30 days of vesting.
On May 18, 2015, pursuant to the Issuer's 2015 Equity Incentive Plan, the Issuer awarded 6,000 RSUs to Rajiv A. Patel ("Patel"), in connection with his appointment as a director of the Issuer in February 2015. Of such RSUs, 500 vested and became convertible on each of May 18 and June 30, 2015; 500 will vest and become convertible on each of September 30 and December 31, 2015; 500 will vest and become convertible on each of March 31, June 30, September 30 and December 31, 2016; and 500 will vest and become convertible on each of March 31, June 30, September 30 and December 31, 2017.
On May 18, 2015, pursuant to the Issuer's 2015 Equity Incentive Plan, the Issuer awarded 1,380 RSUs to Patel in connection with the Issuer's annual award of equity interests to its directors. Of such RSUs, 480 vested and became convertible on May 18, 2015; and 900 vested and became convertible on June 30, 2015.
The amount of securities shown in this row is owned directly by Akubra Investors, LLC ("Akubra"), Bushranger Funding, LLC ("Bushranger") and Ute Holdings, LLC ("Ute" and, together with Akubra and Bushranger, the "Farallon SPVs"). All of such securities, and information relating to beneficial ownership thereof, were previously reported on Forms 3 filed on February 4, 2015 and Forms 4 filed on February 11, 2015 (collectively, the "Prior Filings") by the Farallon SPVs, Farallon Partners, L.L.C. (the "Farallon General Partner"), Farallon Capital Management, L.L.C. (the "Management Company"), NGP, L.L.C. (the "NSSP General Partner"), Farallon AA GP, L.L.C. (the "FCAAI General Partner"), Farallon Partners GP VI, L.L.C. (the "FSSP VI General Partner") and the related individuals identified therein as the "Managing Members" and the "Senior Managing Member."
Other than the transactions by Patel reported in this Form 4, since the Prior Filings there have been no transactions in such securities by any such entities or individuals named in the Prior Filings.
Patel, as a managing member of both the Farallon General Partner and the Management Company, and as a manager of both the FCAAI General Partner and the FSSP VI General Partner, in each case with the power to exercise investment discretion, may be deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. Patel disclaims any beneficial ownership of any of the Issuer's securities reported in this row for purposes of Section 16 of the Securities Exchange Act of 1934 Act, as amended, or otherwise, except to the extent of his pecuniary interest, if any.
Patel, the Farallon SPVs, the Farallon General Partner, the Management Company, the NSSP General Partner, the FCAAI General Partner, the FSSP VI General Partner and each of Managing Members and the Senior Managing Member may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that the foregoing entities and individuals are members of such group.
/s/ Rajiv A. Patel
2015-07-01